Clinical Trial Update: Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients [Phase 3]

View source ↗

Summary

Phase III trial update for valaciclovir hydrochloride in hematopoietic stem cell transplant patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex

Drugs mentioned

• Valaciclovir hydrochloride (valaciclovir hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED | Results posted: 2014-02-24